French researchers have developed a noninvasive ultrasound therapy to treat certain patients with aortic stenosis. In a small study published in The Lancet, they demonstrated its effectiveness.

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, ...

JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for ...

Valvosoft has been authorised to treat patients with severe symptomatic aortic stenosis (sSAS) who may be ineligible for other treatments such as transcatheter aortic valve replacement (TAVR). Image ...

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition ...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today ...

Delivering short pulses of high-pressure ultrasound to calcified bioprostheses may soften the valves and relieve stenosis, new preclinical and in vitro data show. The hope is that one day, with ...

Butterfly Network Inc. (NYSE:BFLY) is one of the most promising penny stocks under $5. On August 5, Butterfly Network announced advancements in AI-powered screening for aortic valve and aorta ...

ELKHART, Ind. (WSBT) — Al Cover is walking and exercising again the way he was a few years ago. “I'm back to where I was before, doing hills. And in my work, my partners recognize the increase in my ...

Transcatheter aortic valve replacement (TAVR) is valve replacement without open-heart surgery. It is also called catheter-based or percutaneous (through the skin) aortic valve replacement. While ...

Aortic stenosis, a narrowing of the aortic valve, affects over 13% of Americans over 75 years old and is often missed until it’s advanced and symptomatic. Studies(1, 2) suggest that a significant ...